Aveanna Healthcare (NASDAQ:AVAH) and Agilon Health (NYSE:AGL) Financial Survey

Agilon Health (NYSE:AGL) and Aveanna Healthcare (NASDAQ:AVAH) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk.

Institutional and Insider Ownership

88.0% of Aveanna Healthcare shares are owned by institutional investors. 2.5% of Agilon Health shares are owned by company insiders. Comparatively, 5.3% of Aveanna Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Risk and Volatility

Agilon Health has a beta of 2.98, suggesting that its share price is 198% more volatile than the S&P 500. Comparatively, Aveanna Healthcare has a beta of 1.95, suggesting that its share price is 95% more volatile than the S&P 500.

Profitability

This table compares Agilon Health and Aveanna Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Agilon Health	-3.92%	-119.38%	-16.85%
Aveanna Healthcare	10.56%	80.70%	7.42%

Valuation and Earnings

This table compares Agilon Health and Aveanna Healthcare”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93 billion	0.25	-$391.35 million	($14.27)	-6.29
Aveanna Healthcare	$2.60 billion	1.12	$225.03 million	$1.23	10.88

Aveanna Healthcare has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Agilon Health and Aveanna Healthcare, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2	6	6	0	2.29
Aveanna Healthcare	0	4	7	1	2.75

Agilon Health currently has a consensus price target of $102.25, indicating a potential upside of 13.99%. Aveanna Healthcare has a consensus price target of $14.06, indicating a potential upside of 5.05%. Given Agilon Health’s higher possible upside, equities research analysts clearly believe Agilon Health is more favorable than Aveanna Healthcare.

Summary

Aveanna Healthcare beats Agilon Health on 12 of the 15 factors compared between the two stocks.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.